Tag Archives: NASDAQ:CELG

Celgene (CELG) Gets a Hold Rating from Mizuho Securities

Mizuho Securities analyst Salim Syed maintained a Hold rating on Celgene (CELG – Research Report) yesterday and set a price target of $100.00. The company’s shares closed last Monday at $102.95, close to its 52-week high of $103.08. According to

Cowen & Co. Reaffirms Their Hold Rating on Celgene (CELG)

Cowen & Co. analyst Yaron Werber maintained a Hold rating on Celgene (CELG – Research Report) today and set a price target of $102. The company’s shares opened today at $92.82, close to its 52-week high of $98.97. According to

New Buy Rating for Celgene (CELG), the Healthcare Giant

In a report released yesterday, Salim Syed from Mizuho Securities maintained a Buy rating on Celgene (CELG – Research Report), with a price target of $103. The company’s shares closed yesterday at $93.88, close to its 52-week high of $98.97.

Mizuho Securities Believes Celgene (NASDAQ: CELG) Still Has Room to Grow

Mizuho Securities analyst Salim Syed reiterated a Buy rating on Celgene (CELG – Research Report) yesterday and set a price target of $103. The company’s shares closed yesterday at $93.47, close to its 52-week high of $98.97. According to TipRanks.com,

Celgene (CELG): New Buy Recommendation for This Healthcare Giant

Mizuho Securities analyst Salim Syed maintained a Buy rating on Celgene (CELG – Research Report) today and set a price target of $103. The company’s shares closed yesterday at $94.96, close to its 52-week high of $97.07. According to TipRanks.com,

Cantor Fitzgerald Keeps a Buy Rating on Celgene (CELG)

Cantor Fitzgerald analyst Alethia Young reiterated a Buy rating on Celgene (CELG – Research Report) yesterday and set a price target of $100. The company’s shares closed yesterday at $83.12. Young wrote: “: Reiterate Overweight rating and $100 price target.